Voya Investment Management LLC Vaxart, Inc. Transaction History

Voya Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.77 - $7.96 $4,956 - $6,837	-859 Reduced 1.82%	46,333 $291,000
Q2 2021 Aug 16, 2021	BUY	$5.06 - $10.78 $126,727 - $269,985	25,045 Added 113.09%	47,192 $353,000
Q1 2021 May 17, 2021	BUY	$5.64 - $23.33 $377 - $1,563	67 Added 0.3%	22,147 $134,000
Q4 2020 Feb 16, 2021	BUY	$3.5 - $7.98 $15,071 - $34,361	4,306 Added 24.23%	22,080 $126,000
Q3 2020 Nov 16, 2020	BUY	$4.78 - $16.97 $12,796 - $45,428	2,677 Added 17.73%	17,774 $118,000
Q2 2020 Aug 14, 2020	BUY	$1.68 - $8.85 $25,362 - $133,608	15,097 New	15,097 $134,000

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.